Skip to main content
    N

    Nutex Health Inc (NUTX)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $169.70
    -3.97 (-2.29%)

    Market Cap: $1.19B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Nutex Health Inc (NUTX) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Nutex Health (NUTX) to earn $27.46 per share in the fiscal year ending Dec 31, 2026, on revenue of $869.99M. Of 6 analysts, 6 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 5 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 1.83, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy116.7%
    Buy583.3%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    6

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 1.8% and revenue estimates rise 10.9%.

    Fiscal year ending Dec 31, 2026
    $27.46
    EPS consensus, revenue $869.99M
    Fiscal year ending Dec 31, 2027
    $27.95
    EPS consensus, revenue $964.79M
    Next report
    Mar 3, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$27.46$26.62 to $28.086$869.99M$864.92M to $874.20M5
    Dec 31, 2027$27.95$24.05 to $31.096$964.79M$946.33M to $996.10M6

    Quarterly Estimates

    The EPS consensus rises from $6.03 for the quarter ending Dec 31, 2026 to $7.09 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$6.03$5.57 to $6.567$231.16M$215.66M to $243.39M7
    Mar 31, 2027$7.09$5.95 to $7.816$234.93M$232.10M to $241.10M6

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 12 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202650
    Fiscal year ending Dec 31, 202750
    Quarter ending Mar 31, 202720

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 2.0% from $28.03.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$27.46$27.37$27.79$27.79$28.03-2.0%
    Fiscal year ending Dec 31, 2027$27.95$27.32$27.87$27.87$27.80+0.5%
    Quarter ending Mar 31, 2027$7.09$7.05$7.33$7.33$7.44-4.7%

    Frequently Asked Questions About NUTX

    What is the NUTX stock forecast?

    Consensus analyst estimates put Nutex Health's EPS at $27.46 for the fiscal year ending Dec 31, 2026, on revenue of $869.99M. The consensus rating from 6 analysts is Buy.

    How do analysts rate NUTX stock?

    Of 6 analysts covering Nutex Health, 1 rates it Strong Buy, 5 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from NUTX next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $27.46, with estimates from $26.62 to $28.08 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $27.95, with estimates from $24.05 to $31.09 from 6 analysts.

    What revenue do analysts expect from Nutex Health next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $869.99M, with estimates from $864.92M to $874.20M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $964.79M, with estimates from $946.33M to $996.10M.

    How many analysts cover NUTX?

    6 analysts rate Nutex Health stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.